EUVIMEDEUVIMED entdecken
Crossref

Early Routine Lung Cancer Screening Leads to Improved Treatment Options and Survival

Jessica L Schweigert iD, Andrew J Borgert, Barbara A Bennie, Brenda L Rooney, Alec J Fitzsimmons, C Isaiah Fitzmaurice, Venki Paramesh

The American Surgeon™ · 2025

DOI: 10.1177/00031348251331280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Jessica L Schweigert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education and Research Navigation, Gundersen Medical Foundation, La Crosse, WI, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is the second-most common cancer and leading cause of cancer-related deaths. American adults aged 55 to 80 years are at heightened risk for lung cancer; only 4.5% underwent screening history by computed tomography. The hypothesis is that lung cancers diagnosed on screening were an earlier stage which broadens treatment options and improves survival.

Methods

The electronic health record (EHR) was retrospectively queried to identify patients with lung cancer from 2017 to 2020. Kaplan-Maier curves were used to compare survival based on screening history.

Results

764 patients with lung cancer were included. 14.7% (112/764) had a history of lung cancer screening. Patients with a history of screening were significantly more likely to be diagnosed at early stages (66/112, 59% vs 215/652, 33%; P < .0001). They were significantly more likely to have surgery (46/112, 41% vs 97/652, 15%, respectively; P < 0.0001). Patients diagnosed in late stages were significantly more likely than those diagnosed at early stages to receive chemotherapy (318/483, 66% vs 76/281, 27%, respectively; P < .0001). Three-year survival was higher with screening ( P < .0001). Survival rates at 3 years after initial diagnosis with screening history is 47.4% (95% CI, 34.8-59.0) while the rate without screening is 25.2% (95% CI, 21.2-29.4).

Discussion

Lung cancer diagnosed via screening was more likely to be earlier stages. Patients diagnosed at early stages were more likely to undergo surgery. Those diagnosed via screening had a higher 3-year survival. These findings indicate that early routine screening leads to improved treatment options and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerHumansAgedRetrospective StudiesFemaleMiddle AgedMaleAged, 80 and overSurvival RateTomography, X-Ray ComputedNeoplasm Staging

Stichwörter der Autor:innen

lung cancerlung cancer screeningtreatment options

Autor:innen und Institutionen

  • Department of Medical Education and Research Navigation, Gundersen Medical Foundation, La Crosse, WI, USA.
  • Department of Cardiothoracic Surgery, Gundersen Health System, La Crosse, WI, USA.

ORCID-Profile: Jessica L Schweigert

Zitieren

APA

Schweigert, J. L., Borgert, A. J., Bennie, B. A., Rooney, B. L., Fitzsimmons, A. J., Fitzmaurice, C. I., & Paramesh, V. (2025). Early Routine Lung Cancer Screening Leads to Improved Treatment Options and Survival. The American Surgeon™. https://doi.org/10.1177/00031348251331280

Vancouver

Schweigert JL, Borgert AJ, Bennie BA, Rooney BL, Fitzsimmons AJ, Fitzmaurice CI, et al. Early Routine Lung Cancer Screening Leads to Improved Treatment Options and Survival. The American Surgeon™. 2025. doi:10.1177/00031348251331280

BibTeX
@article{Schweigert2025,
  author = {Schweigert, Jessica L and Borgert, Andrew J and Bennie, Barbara A and Rooney, Brenda L and Fitzsimmons, Alec J and Fitzmaurice, C Isaiah and Paramesh, Venki},
  title = {Early Routine Lung Cancer Screening Leads to Improved Treatment Options and Survival},
  journal = {The American Surgeon™},
  year = {2025},
  doi = {10.1177/00031348251331280}
}
Kostenlos starten →